S6E5: Tackling unmet needs: new compounds in development for non-functioning pituitary adenomas and rare endocrine diseases

<p>In today's podcast, we highlight a new company dedicated to the rare endocrine disease world.  <a href='https://www.tiburio.com'>Tiburio Therapeutics</a> is working on <a href='https://www.tiburio.com/our-programs/'>two exciting compounds</a> for the treatment of <a href='https://www.pituitaryworldnews.org/podcast-non-functioning-pituitary-adenomas/'>Non-functioning Pituitary Adenomas</a> and rare endocrine disorders.</p> <p>Last week Dr. Blevins and I caught up with<a href='https://www.tiburio.com/who-we-are/management-team/'> Abe Ceesay, Tiburio CEO and Nerissa Kreher M.D., Chief Medical Officer</a>, both highly experienced professionals in the rare endocrine space. We had a fascinating talk about their plans in this area of extensive need for patients. Here’s our talk.</p>